Gallicchio earned his Ph.D. in Experimental Hematology at New York University Medical Center and completed fellowships in hematology at the Sloan Kettering Institute for Cancer Research and at the University of Connecticut Health Center. He was awarded a diploma in internal medicine from the “Vasile Goldis” University of Arad (Romania). He has served on the faculty at Yale University School of Medicine, University of Kentucky Medical Center, University of Central Lancashire (England), and University of Wolverhampton (England). He has served as President of Alpha Eta Honor Society, the International Society for Lithium Research, International Federation of Biomedical Laboratory Science and currently serves as Vice President of the Educational and Research Centers in Trace Elements operated under the auspice of UNESCO. He is a Fellow of the Association of Clinical Scientists, the Association of Schools of Allied Health Professions, and the Royal Society of the Arts. In 2003, at a 200th anniversary RSA event, because of his long-standing effort to educate and train biomedical laboratory science students from England, Dr. Gallicchio was recognized for his efforts by being presented to Her Majesty, Queen Elizabeth II. Dr. Vincent S. Gallicchio has 45 years experience in academic medicine and research covering experimental hematology, immunology, stem cell biology, and developmental therapeutics for human diseases such as AIDS and cancer. He has earned national and international recognition for his efforts. In a first time study reporting on academic scholarly productivity in the Journal of Clinical Laboratory Science, Dr. Gallicchio was rated the number one academic biomedical laboratory science researcher in the United States. His rating of 551 was nearly twice that of the next closest professor’s score of 285. Additionally, during his leadership, the academic program in Clinical Laboratory Science at the University of Kentucky Medical Center was rated the number one program of its kind among 127 in the nation. His passion for research, a high value placed on excellence, a strong reputation as an esteemed collaborator, and a tenacious desire to see a better therapies for human diseases brought to market speak to his overall character.
Stem cell biology, Alternative non-psychiatric medical applications of lithum, Preclinical drug pharmacology for AIDS and cancer
Dr. Williams is a DVM with over 35 years’ experience performing translational research using different animal models of human disease. He has published over 120 full length manuscripts and 20 chapters and reviews. His focus is on women’s health and recently on regenerative medicine approaches to restoration of the urinary sphincter for women with urinary incontinence. This presentation is a review of determinates of cell therapy efficacy on urinary incontinence using nonhuman primates as an animal model of aging, chronicity of disease, estrogen deficiency, and obesity. The presentation concludes with a discussion of regenerative pharmacologic approaches for these different populations.
Estrogen Replacement Therapy, Apolipoproteins E, Estradiol, Estrogens, Atherosclerosis